Back to top

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$228.34 USD


-3.30 (-1.42%)

Updated Sep 27, 2022 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.63%
5Strong Sell2.32%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 13% (218 out of 251)

Industry: Medical - Dental Supplies

Trades from $1

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

BD's (BDX) Latest PFS Launch to Boost Production Efficiencies

BD's (BDX) newest product offering is expected to set a new standard in performance for vaccine PFS with new and strict specifications for improved production efficiencies.

Implied Volatility Surging for BD (BDX) Stock Options

Investors need to pay close attention to BD (BDX) stock based on the movements in the options market lately.

Here's Why You Should Hold on to BD (BDX) Stock for Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.

BD's (BDX) Latest Collaboration to Boost Patient Outcome

BD's (BDX) tie-up with Accelerate Diagnostics is expected to strengthen the fight to combat the global threat of antimicrobial resistance, thereby boosting patient care.

BD (BDX) Ties Up With LabCorp to Boost Patient Outcome

BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.

Zimmer Biomet (ZBH) Sees Business Recovery, Global Growth

Zimmer Biomet (ZBH) revenues ride on continued execution along with strong COVID recovery across most markets.

Cardiovascular Systems (CSII) Q4 Earnings, Revenues Miss Mark

According to Cardiovascular Systems (CSII), strong sequential growth in each of its segments is due to procedure recovery, focused commercial strategies and the launch of products.

Nevro (NVRO) Q2 Earnings Beat Estimates, FY22 View Revised

Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q2, partly owing to robust domestic performance.

QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View

QuidelOrtho's (QDEL) robust performance across majority of its business units and geographies drives its second-quarter 2022 top line.

AMN Healthcare (AMN) Q2 Earnings, Revenues Beat Estimates

AMN Healthcare's (AMN) robust Q2 results demonstrate its segmental strength.

BD (BDX) Beats on Q3 Earnings and Revenues, Raises FY22 View

The majority of BD's (BDX) core units witness strong revenue growth in the fiscal third quarter.

Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 6.83% and 4.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

Medical Device Stocks Earnings on Aug 4: BDX, ABMD, AMN & DOCS

The Medical Device companies' Q2 results are likely to reflect strength in customer demand. Let's see how BDX, ABMD, AMN and DOCS are placed ahead of their earnings releases.

Zacks Industry Outlook Highlights Becton, Dickinson and Company, Patterson Companies and SmileDirectClub

Becton, Dickinson and Company, Patterson Companies and SmileDirectClub are part of Zacks Industry Outlook article.

BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?

Continued strength in BD's (BDX) Interventional segment is expected to have driven up Q3 sales.

3 Dental Supplies Stocks to Buy Amid Industry Headwinds

Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, PDCO and SDC.

Analysts Estimate Becton Dickinson (BDX) to Report a Decline in Earnings: What to Look Out for

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BDX or ALGN: Which Is the Better Value Stock Right Now?

BDX vs. ALGN: Which Stock Is the Better Value Option?

Sheraz Mian headshot

Earnings Season Scorecard and Fresh Analyst Research Reports for Chevron, Adobe & AMD

Today's Research Daily features update on the Q2 earnings season and new research reports on Chevron (CVX), Adobe (ADBE), AMD (AMD) and 16 other stocks.

3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.

3 Reasons to Add Accuray (ARAY) Stock to Your Portfolio Now

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

Cardinal Health's (CAH) New Buyout to Boost Medication Adherence

Cardinal Health's (CAH) latest acquisition is expected to significantly improve patients' health outcomes with improved medication adherence and increased satisfaction.

BDX vs. ALGN: Which Stock Is the Better Value Option?

BDX vs. ALGN: Which Stock Is the Better Value Option?

BD's (BDX) New Combination Test to Boost Patient Outcome

BD's (BDX) latest combination test is expected to speed up the detection of the infection-causing viruses, thereby accelerating the implementation of the appropriate treatment plan.

BD (BDX) Integrates Innovative Solution to Boost Patient Care

BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.